Halozyme Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 342k | 73.34 |
| 2025-06-30 | $21M | 399k | 52.02 |
| 2025-03-31 | $22M | 344k | 63.81 |
| 2024-12-31 | $6.9M | 145k | 47.81 |
| 2024-09-30 | $7.7M | 135k | 57.24 |
| 2024-06-30 | $7.2M | 137k | 52.36 |
| 2023-12-31 | $5.2M | 140k | 36.96 |
| 2023-09-30 | $5.4M | 141k | 38.20 |
| 2023-06-30 | $5.3M | 147k | 36.07 |
| 2023-03-31 | $5.7M | 150k | 38.19 |
| 2022-12-31 | $8.7M | 152k | 56.90 |
| 2022-09-30 | $6.2M | 158k | 39.54 |
| 2022-06-30 | $6.9M | 157k | 44.00 |
| 2022-03-31 | $6.5M | 162k | 39.88 |
| 2021-12-31 | $4.7M | 116k | 40.21 |
| 2021-09-30 | $4.8M | 119k | 40.68 |
| 2021-06-30 | $5.3M | 117k | 45.41 |
| 2021-03-31 | $4.8M | 116k | 41.69 |
| 2020-12-31 | $5.2M | 123k | 42.71 |
| 2020-09-30 | $1.6M | 60k | 26.28 |
| 2020-06-30 | $1.6M | 60k | 26.81 |
| 2020-03-31 | $1.0M | 57k | 17.99 |
| 2019-12-31 | $1.1M | 65k | 17.74 |
| 2019-09-30 | $1.0M | 65k | 15.51 |
| 2019-06-30 | $958k | 56k | 17.18 |
| 2019-03-31 | $897k | 56k | 16.10 |
| 2018-12-31 | $815k | 56k | 14.63 |
| 2018-09-30 | $1.6M | 88k | 18.17 |
| 2018-06-30 | $940k | 56k | 16.87 |
| 2018-03-31 | $1.1M | 56k | 19.59 |
| 2017-12-31 | $1.1M | 56k | 20.26 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors